Independent Registries Are Cost-Effective Tools to Provide Mandatory Postauthorization Surveillance for Orphan Medicinal Products

Sirrs, SM; Arthus, MF; Bichet, DG; Rockman-Greenberg, C; LeMoine, K; Morel, CF; Lachmann, R; Lynd, LD; Wasim, S; West, ML; Hollak, C

Sirrs, SM (corresponding author), Level 4,2775 Laurel St, Vancouver, BC V5Z 1M9, Canada.

VALUE IN HEALTH, 2021; 24 (2): 268

Abstract

Objectives: Orphan medicinal products (OMPs) often receive market authorization under conditions imposed by regulators for ongoing postauthorization s......

Full Text Link